Scalp application of the antioxidant piroctone olamine reduces hair shedding in an 8‐week randomized, double‐blind, placebo‐controlled clinical study
Year: 2021
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.1111/ics.12737
Institutions: Procter & Gamble (United States), Cleveland Clinic
Language: English
Topic: Hair Growth and Disorders
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Procter and Gamble
OpenAlex ID: W3193349136
